Literature DB >> 2743677

Magnetic resonance imaging of the ischemic hip. Alterations within the osteonecrotic, viable, and reactive zones.

D G Mitchell1, M E Steinberg, M K Dalinka, V M Rao, M Fallon, H Y Kressel.   

Abstract

To explore the ability of magnetic resonance imaging (MRI) to depict the morphologic features of avascular necrosis (AVN) of the femoral head and to determine whether a classification based on stage of necrosis is possible, images of hips with 56 proved lesions were examined and correlated with roentgenographic stage, severity of pain and functional impairment, and available computed tomography (CT) scans. Six femoral heads with AVN were also studied ex vivo with MRI, CT, roentgenographic, and histologic examinations. These examinations were compared with 100 normal hips in 50 individuals and one normal proximal femoral specimen. The reactive interface between live and dead bone at the periphery of AVN lesions had a characteristic MRI appearance that facilitated diagnosis. Based on central signal intensity on two different pulse sequences, lesions could be separated into four classes that correlated with roentgenographic and clinical staging. Lesions that were isointense with fat on both sequences had an earlier roentgenographic stage and less severe symptoms than did lesions that were less intense than fat. Among hips with AVN in patients younger than 50 years of age, 67% had premature conversion to fatty intertrochanteric marrow outside the borders of the lesion. Detecting premature conversion to fatty marrow has important implications regarding the pathogenesis of AVN and may aid early diagnosis. MRI provides pathophysiologic information that is different from information obtained from conventional methods or various combinations of methods and may provide a basis for an improved system for grading AVN lesions.

Entities:  

Mesh:

Year:  1989        PMID: 2743677

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  11 in total

1.  Case report 662. Bilateral avascular necrosis of femur, with supervening suppurative arthritis of right hip.

Authors:  M A Nuovo; H A Sissons; J D Zuckerman
Journal:  Skeletal Radiol       Date:  1991       Impact factor: 2.199

2.  Vascularized bone grafting in a canine carpal avascular necrosis model.

Authors:  Wouter F Willems; Gregory M Alberton; Allen T Bishop; Thomas Kremer
Journal:  Clin Orthop Relat Res       Date:  2011-04-30       Impact factor: 4.176

3.  Pathology of osteonecrosis of the femoral head. A review of experience at the Hospital for Joint Diseases, New York.

Authors:  H A Sissons; M A Nuovo; G C Steiner
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

4.  Traumatic hip dislocation: early MRI findings.

Authors:  A Laorr; A Greenspan; M W Anderson; H D Moehring; T McKinley
Journal:  Skeletal Radiol       Date:  1995-05       Impact factor: 2.199

5.  Osteonecrosis of femoral head: Treatment by core decompression and vascular pedicle grafting.

Authors:  Sudhir Babhulkar
Journal:  Indian J Orthop       Date:  2009-01       Impact factor: 1.251

Review 6.  [Pathohistology of femoral head necrosis].

Authors:  G Delling
Journal:  Orthopade       Date:  2007-05       Impact factor: 1.087

7.  A tissue engineering strategy for the treatment of avascular necrosis of the femoral head.

Authors:  A Aarvold; J O Smith; E R Tayton; A M H Jones; J I Dawson; S Lanham; A Briscoe; D G Dunlop; R O C Oreffo
Journal:  Surgeon       Date:  2013-03-27       Impact factor: 2.392

8.  Management of avascular necrosis of femoral head at pre-collapse stage.

Authors:  Ramesh Kumar Sen
Journal:  Indian J Orthop       Date:  2009-01       Impact factor: 1.251

9.  Osteonecrosis in systemic lupus erythematosus: an early, frequent, and not always symptomatic complication.

Authors:  Paola Caramaschi; Domenico Biasi; Ilaria Dal Forno; Silvano Adami
Journal:  Autoimmune Dis       Date:  2012-08-05

10.  Rationale for prostaglandin I2 in bone marrow oedema--from theory to application.

Authors:  Marcus Jäger; Frank Peter Tillmann; Thomas S Thornhill; Marcus Mahmoudi; Dirk Blondin; Gerd Rüdiger Hetzel; Christoph Zilkens; Rüdiger Krauspe
Journal:  Arthritis Res Ther       Date:  2008-10-03       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.